|
A Phase I Trial of CC-5013 (lenalidomide) in Pediatric Patients with Recurrent or
|
ZIA BC 010585
|
$67,807
|
Warren, Katherine
|
CCR (NCI)
|
|
Academic Training in Medical Oncology
|
5T32CA009297-27
|
$304,451
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
American College of Radiology Imaging Network
|
5U01CA080098-12
|
$9,041,302
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
An Exploratory Study of Biologic and Pathophysiologic Efects of Radiation Therap
|
ZIA BC 010709
|
$271,230
|
Warren, Katherine
|
CCR (NCI)
|
|
Analyses of the Molecular Functions for D-Cyclins
|
5R01CA108420-07
|
$461,278
|
SICINSKI, PIOTR
|
DANA-FARBER CANCER INSTITUTE
|
|
Analysis of the VHL-HIF hydroxylase pathway
|
5R01CA125020-04
|
$221,920
|
SHIIO, YUZURU
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S1
|
$100,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S2
|
$143,893
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S3
|
$100,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-32
|
$4,161,905
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Brain Tumor Clinical and Clinical Research Program
|
ZID BC 011098
|
$2,375,426
|
Fine, Howard
|
CCR (NCI)
|
|
Brain tumor family study of genetic susceptibility and environmental factors
|
ZIA CP005803 08050
|
$224,710
|
Goldstein, Alisa
|
DCEG (NCI)
|
|
Breast implant follow-up study
|
ZIA CP010128 01220
|
$31,739
|
Brinton, Louise
|
DCEG (NCI)
|
|
Cancer Center Support Grant
|
3P30CA044579-20S2
|
$99,998
|
WEBER, MICHAEL
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
|
Cancer Center Support Grant
|
3P30CA044579-20S3
|
$50,000
|
WEBER, MICHAEL
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
|
Cancer Center Support Grant
|
5P30CA044579-20
|
$2,410,577
|
WEBER, MICHAEL
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
|
Cancer Center Support Grant (CCSG)
|
3P30CA021765-32S1
|
$126,000
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant (CCSG)
|
3P30CA021765-32S2
|
$100,000
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant (CCSG)
|
3P30CA021765-32S3
|
$50,000
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant (CCSG)
|
3P30CA021765-32S4
|
$100,000
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant (CCSG)
|
5P30CA021765-32
|
$5,973,490
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Therapy & Research Center at UTHSCSA
|
3P30CA054174-18S1
|
$99,979
|
Thompson, Ian
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Cancer Therapy & Research Center at UTHSCSA
|
5P30CA054174-18
|
$1,368,979
|
Thompson, Ian
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Clinical Development of Novel Drugs for Children with Refractory Cancers
|
ZIA SC 010354
|
$570,045
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$837,024
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$558,016
|
Linehan, W. Marston
|
CCR (NCI)
|
|
CNS vulnerability to systemic chemotherapy: Causes and prevention
|
5R01CA131385-03
|
$319,550
|
NOBLE, MARK
|
UNIVERSITY OF ROCHESTER
|
|
Community Clinical Oncology Program
|
2U10CA037422-23
|
$4,179,081
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
3U10CA037422-22S2
|
$28,500
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
3U10CA037422-22S3
|
$1,208,966
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Consequences of receptor cross talk on inflammation and algesia
|
ZIA BC 010708
|
$71,275
|
Oppenheim, Joost
|
CCR (NCI)
|
|
Cutaneous Lesions in Neurofibromatosis Type I and Other Pre-cancerous Syndromes
|
ZIA BC 010734
|
$45,210
|
Hornyak, Thomas
|
CCR (NCI)
|
|
Determining the Fate of Transmembrane Proteins
|
ZIA BC 009392
|
$784,104
|
Weissman, Allan
|
CCR (NCI)
|
|
Development of Mouse Astrocytoma Model for Preclinical Testing
|
ZIA BC 010541
|
$104,783
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Development of Therapies for Neurofibromatosis Type 1 Related Tumors and other Ge
|
ZIA BC 010801
|
$855,068
|
Widemann, Brigitte
|
CCR (NCI)
|
|
DNA Damage Responses in B Cell Development
|
5R21CA133781-02
|
$186,235
|
MANIS, JOHN
|
CHILDREN'S HOSPITAL BOSTON
|
|
DNA Repair in Human Cancer-Prone Genetic Diseases
|
ZIA BC 004517
|
$1,279,378
|
Kraemer, Kenneth
|
CCR (NCI)
|
|
Emory Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-02S1
|
$49,963
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Emory Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-02S2
|
$115,904
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Emory Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-02S3
|
$99,946
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Emory Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-02
|
$1,428,397
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
FEN-1 and PCNA Complexes and Human Genome Stability
|
5R01CA081967-11
|
$351,219
|
TAINER, JOHN
|
UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$882,683
|
Gottesman, Michael
|
CCR (NCI)
|
|
Histologic and Molecular Characterization of Solid Pediatric Tumors
|
ZIC SC 009431
|
$292,952
|
Tsokos, Maria
|
CCR (NCI)
|
|
Huntington Interacting Protein-1(HIP1) and the Promotion of Neoplasia
|
5R01CA098730-07
|
$265,965
|
ROSS, THEODORA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Identification of Genes for Predicting Prognosis in Pediatric Cancers
|
ZIA SC 010366
|
$461,638
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma
|
ZIA BC 010539
|
$628,696
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$627,828
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Novel Protein Phosphatases in the ATM Signaling Pathway
|
5R03CA142605-02
|
$69,768
|
LU, XIONGBIN
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
|
IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
|
ZIA SC 004002
|
$1,230,133
|
Waldmann, Thomas
|
CCR (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|